{"version":"1.0","type":"link","title":"Cotargeting DNA topoisomerase II enhances efficacy of RAS-targeted therapy in KRAS-mutant cancer models.","author_name":"Xu R 외","author_url":"https://prs-insight.online/author/Xu%20R","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97134","thumbnail_width":1200,"thumbnail_height":630}